Delivery Order SPE2DB24D2105-SPE2DB24FAQDK

Award Date 9/25/24
Potential Completion Date 9/26/24
Potential Value $49K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA). The $25,069.68 firm fixed-price delivery order was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 18, 2024. This award is a child under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $8,751.31 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 12, 2024 with an ultimate completion date of November 13, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite...
This federal contract award is for the delivery of MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 22, 2024, with a ceiling value of $2,630.00 and a completion date of August 23, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $1,026.51, was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the federal government. The contract is a delivery order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA,...
This federal contract award is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $11,147.42 firm fixed price contract was awarded to prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 3, 2024 and was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite...
This federal contract award is for the delivery of the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA). The $4,991.94 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 12, 2024, with a completion date of November 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $2,720.90 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on July 3, 2025 with a completion date of July 7, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a substantial...
This federal contract award is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $5,260.00, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC...
This federal contract award is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,578.00, was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which...
This federal contract award is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML medical products to the Defense Logistics Agency (DLA). The $16,654.10 Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 22, 2024 and was awarded on October 21, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by...
  • SPE2DB24D2105
    Indefinite Delivery Contract
  • SPE2DB24D2105-SPE2DB24FAQDK
    Delivery Order

This federal contract award is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $49,067.29 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 25, 2024, with a completion date of September 26, 2024. The contract is not set aside and is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of medical commodities, including prescription drugs, from Amerisourcebergen to support military treatment programs and facilities worldwide.

Generated 12/25/24, 9:17 AM